Pharmacy Deliveries Take Flight: Can Drones Solve America’s Pharmacy Access Gap?

Drone delivery of medications is transitioning from beta testing to early operationalization in the US. This shift has been driven by persistent last-mile access barriers, the clinical value of shorter time-to-therapy for selected conditions, and the need for robust logistics during disruptions (eg, severe weather or flooding).

A key equity driver is the distribution of pharmacy deserts. In national geospatial work, pharmacy deserts have been defined as census tracts meeting both low-income and low-access criteria; the low-access criterion included thresholds of at least 33% of residents living 1 mile or further from a pharmacy in urban tracts, more than 5 miles in suburban tracts, and more than 10 miles in rural tracts (with an additional 0.5-mile threshold for tracts with <100 car owners).¹ Newer 2026 data have indicated that nearly half of US counties qualify as pharmacy deserts, with pharmacy closures accelerating since 2018 and disproportionately affecting rural and underserved communities.²

Drone-based delivery is emerging to improve medication access for patients in rural communities and those with mobility limitations. Beyond its established role in disaster response, it offers potential for enhanced patient delivery where timely access to therapies remains a challenge. Persistent barriers (eg, geographic isolation, transportation limitations, workforce shortages) continue to delay care in many areas of the US.

Early implementations and pilot programs have suggested improvements in delivery speed, expanded reach, and maintenance of cold-chain requirements for sensitive medications. These developments highlight the potential of drone technology to enhance access, efficiency, and continuity of pharmacy care.^1,3-6

Access and Clinical Rationale (Why Medications)

Medication delivery is a health-critical workflow: it must integrate pharmacy dispensing regulations, chain-of-custody controls, patient privacy, and safety management. The access rationale is substantial. A national geospatial analysis estimated 15.8 million people (which is approximately 4.7% of the US population) live in pharmacy deserts.¹

Pharmacy deserts are typically communities or census tracts that are both low-income and have poor physical access to pharmacies. A standard definition characterized a pharmacy desert as a census tract where over one-third of residents live beyond a reasonable distance from a pharmacy, usually over 1 mile in urban regions, 10 miles in rural areas, and 0.5 miles in regions with low vehicle availability, and that is also classified as low-income.⁷

Using an alternative vulnerability-index approach, another national analysis projected 57.1 million individuals (17.7%) reside in pharmacy deserts, and 28.9 million (8.9%) rely on a single “keystone” pharmacy for access—figures that highlight fragility in medication access as closures and consolidation continue.³ In rural and disaster-prone areas, limited and unreliable transportation systems further restrict access to essential services and care.⁴

Additional federal-agency examples further illustrate the seriousness of these access gaps in the US. CMS uses pharmacy-convenient access thresholds that already recognize substantial rural travel burdens: plans are evaluated using distance standards of 2 miles in urban areas, 5 miles in suburban areas, and 15 miles in rural areas.⁸ Federal Indian Health Service reporting likewise shows that many American Indian and Alaska Native communities face structural access barriers, with IHS facilities distributed across 37 states and about 660 locations, making distance, transportation limits, and environmental conditions important barriers for many rural communities.⁹

Access constraints are clinically relevant when delays in initiating therapy meaningfully change outcomes or symptom burden, and operationally relevant when mobility limitations, traffic congestion, or storm/flood disruptions impair routine delivery. The CDC documented severe pharmacy disruption after disasters¹⁰:

• After Hurricane Maria, only about 29% of pharmacies reporting to Healthcare Ready in Puerto Rico were open 5 days after landfall.
• After Hurricane Ivan near Mobile, Alabama, approximately 53% of pharmacies in affected areas had depleted supplies, and at least 26% had to prioritize distribution because of shortages.
• Among Hurricane Katrina evacuees in San Antonio, Texas, approximately 68% requested medications for chronic conditions.

Beyond disaster response, drone-based medication delivery could help alleviate pharmacy deserts by overcoming geographic and transportation challenges in rural and high-risk communities on a routine basis.

Emerging evidence has indicated that drone-based medication delivery could help reduce some lack of access caused by pharmacy deserts by overcoming geographic and transportation challenges in rural and high-risk communities. A study from Virginia’s Eastern Shore in the US modeled drone delivery to enhance medication access in flood-prone, transport-vulnerable areas.

Additionally, wider pharmacy-policy research views drone-enabled medication delivery as a promising logistical solution for underserved regions.⁴ Cost analyses suggested that drone delivery may be competitive with or lower than traditional mail or courier services for last-mile distribution, with estimates as low as approximately $1 to $1.23 per delivery compared with over $5 for conventional short-distance delivery, including about $5.33 for a 4-mile trip using an electric van.¹¹

Regulatory and Governance Landscape (US)

Routine drone delivery of medications typically requires advanced operations (eg, beyond visual line of sight [BVLOS]) with them. It therefore often aligns with the Federal Aviation Administration’s Part 135 aircarrier pathway for package delivery. The FAA describes Part 135 certification as the existing pathway for small-package delivery and notes that applicants must complete a multiphase certification process.⁵

As of early 2026, several operators hold 14 CFR Part 119 aircarrier certificates with Part 135 authority, including Zipline (the first fixed-wing UAS operator) and Amazon Prime Air (the first to be certified for drones >55 lb).

Environmental review and community impact management are increasingly central to scaling (noise, flight frequency, route selection, and community acceptance). The FAA’s NEPA materials and associated environmental assessments provide quantitative expectations for operating scale, aircraft characteristics, and hours of operation for multiple operators.⁶

The FAA’s draft Programmatic Environmental Assessment (PEA) states drone package delivery typically operates within a 5- to 10-mile radius of a delivery hub. It describes Part 135 certification as the only path to carrying another party’s property for compensation or to operate BVLOS.¹² The FAA released its Draft PEA for nationwide Part 135 drone package delivery in December 2025; the public comment period closed in January 2026.

State regulation also plays a critical role, as some boards now explicitly address drone delivery. For example, Texas permits drone-based prescription delivery with restrictions on controlled substances and requirements for secure handling, while Virginia clarifies that existing drug delivery standards apply equally to drones, including safeguards for integrity and temperature control.^13,14 State action remains uneven, and in many jurisdictions publicly available board-of-pharmacy rules for pharmacy-to-patient drone delivery have not yet been issued, leaving programs to rely on general prescription-delivery standards unless or until state-specific guidance is adopted.^9,13,14

Practical Aviation Perspective

From a commercial fixed-wing and Part 107 pilot viewpoint, Part 135 certification represents a significant maturation beyond recreational or Part 107 limitations. Fixed-wing platforms (eg, Zipline) offer superior range and endurance for rural medical payloads—often 50 to 120 or more miles round-trip, compared to about 4 to 12 miles for multicopper—while maintaining higher payload capacity in varied weather conditions. Multicopper excels in precise, short-radius urban or campus deliveries but faces greater battery and wind constraints. Detect-and-avoid technology, redundant systems, and formal maintenance programs required under Part 135 are essential for medication integrity and public safety. Pharmacists partnering in these operations must understand that chain-of-custody handoffs now occur under formal air-carrier protocols, with documented temperature logs, tamper-evident packaging, and exception handling (eg, weather aborts) that mirror pharmaceutical good-distribution practices.

Operational Models Used for Medication Delivery

US medication drone delivery has generally followed 2 archetypes:

• Pharmacy-to-patient (direct-to-community) model.
  • A dispensing pharmacy packages medications and hands them off to a drone operator for transport to a community drop site or, in more advanced concepts, directly to residences. Operational requirements include patient identity verification upon receipt, secure, tamper-evident packaging, and robust exception handling (weather aborts, returns, wrong addresses).
• Health-system or distributor-to-care-site model (interfacility or microfulfillment).
  • Drones move pharmaceuticals and medical products to clinics or local nodes to improve availability and enable same-day dispensing by a local pharmacy partner. This model may simplify patient-facing handoff but still requires rigorous inventory control and validated handling/temperature management where relevant.

Both models benefit from fixed-wing efficiency for longer rural hauls and multicopper precision for last-meter accuracy.

Quantitative Metrics and Benchmarks (Selected)

The Table summarizes quantitative metrics drawn from peer-reviewed studies and authoritative public sources. These values are context-dependent (geography, airspace approvals, aircraft type, and workflow design) but provide practical benchmarks for U.S. implementation planning.

Across studies, access‑need estimates range from 15.8 million to 57.1 million people living in pharmacy deserts, and rural coastal modeling suggests that more than 82% of residents could be reached by drone within 10 minutes. Operational benchmarks span, at most, a 60‑minute consumer prescription delivery pilots, small‑cargo payloads of roughly 2–10 lb (and up to about 8 lb in proposed scaled operations), and cold‑chain packaging sustaining 2 to 8°C.

Key US Implementations and Pilots (Illustrative Examples)

Virginia Eastern Shore (Eastern Shore of Virginia, including Tangier Island): In a peer-reviewed case study, drone delivery was modeled as a resilience intervention for flood-prone coastal communities. The analysis quantified time-zone coverage and showed substantial reductions in time to obtain medications for older adults and remote residents.⁴

Riverside Health plus DroneUp (hypertension medications): A multipartner pilot on Virginia’s Eastern Shore reported 3 successful hypertension-medication deliveries within a 2-mile radius of Riverside Shore Memorial Hospital and described payload capacity up to 10 pounds for ongoing cadence deliveries.¹⁵

Crisfield/Smith Island, Maryland: In 2025, the University of Maryland UAS Research and Operations Center (UROC), in partnership with DroneUp and local pharmacies, launched a US Department of Transportation-funded pilot delivering prescription medications from Crisfield (mainland) pharmacies to patients in Somerset County. Stage 1 demonstrations (September 2025) completed successful mainland deliveries. Phase 2 (planned for January 2026) targets deliveries to remote Smith Island (about 200 residents, accessible only by boat, no local pharmacy). The project addresses transportation gaps for older and homebound residents and may expand to lab specimens or emergency supplies.¹⁶

Cleveland Clinic/Zipline (Northeast Ohio): Cleveland Clinic plans to use Zipline’s Platform 2 fixed-wing system to deliver specialty and rush medications directly to patient homes from more than a dozen Northeast Ohio facilities, with rollout targeted for 2025. The goal includes ~10-minute deliveries, with potential future expansion to lab samples and home medical supplies. ¹⁷

UPS Flight Forward plus Atrium Health Wake Forest Baptist (cold-chain vaccines and pharmaceuticals): UPS described a drone-enabled cold-chain workflow using custom packaging designed to maintain 2-8 °C, equipped with a temperature-monitoring device. UPS also reported that drone delivery within 10 minutes is operationally valuable for specialty infusion medicines and that clinic-shuttle drone operations can improve pharmacy productivity by up to 30%. ¹⁸

Amazon Pharmacy plus Prime Air (College Station, Texas): Amazon reported prescription delivery by drone in 60 minutes or less for eligible customers, with access to more than 500 medications, and described operational parameters, including flight altitude (40-120 m) and the number of deliveries since December 2022.¹⁹ Importantly for rural contexts, Amazon’s broader same-day prescription expansion (targeting nearly 4,500 cities and towns by end-2026) relies primarily on ground logistics, reaching remote areas such as parts of the Navajo Nation and Alaska towns, where the nearest pharmacy can be 45 to 60 or more minutes away. Drone operations remain concentrated in suburban/semi-rural test markets rather than deep rural home delivery.²⁰ Hospital-campus models have scaled more readily than widespread patient-home rural delivery, which still faces payload, range, and regulatory hurdles.

News reporting on the same program described package release procedures (descending to low altitude and releasing a padded package) and emphasized that the pilot targeted noncontrolled medications for common acute conditions.²¹

What is Supported and What Remains Uncertain

The literature on healthcare drone delivery is expanding. Still, the strongest evidence remains concentrated in feasibility, time savings, routing/optimization, and user acceptance, with fewer studies linking prescription drone delivery to clinical outcomes. US-relevant evidence is emerging through geographically explicit studies (eg, coastal Virginia) that quantify access gains and provide operational assumptions.⁴

User acceptance is a practical determinant of adoption. In a participatory design study of a drone-based medication delivery service, usability correlated strongly with intention to use, and a model including usefulness, skepticism, and curiosity explained most of the variance in intention.²²

Environmental performance is context-dependent. Life-cycle analyses indicate drones can reduce emissions relative to diesel trucks in some scenarios. Still, benefits depend on vehicle type, operational design (takeoff/landing intensity), electricity mix, and the extent of additional warehousing required.^23,24

Implementation Considerations Specific to Medications

Medication delivery introduces additional constraints beyond standard parcels, including security measures like tamper-evident packaging and documented handoffs; clinical approval, often starting with stable, noncontrolled medications; temperature control with validated cold-chain packaging; community impacts such as noise, privacy, and flight regulations; and addressing equity to prevent disparities, for example, excluding those without smartphones or stable addresses.

Conclusion

Drone-delivered medication in the US offers a practical solution to improve access in rural areas and during emergencies. Success hinges on monitoring delivery times, failure rates, temperature, regulatory approval, and patient satisfaction. Widespread use requires state-by-state regulation, FAA approval, safety protocols, and community support. Drone delivery reduces pharmacy deserts and enhances rural healthcare by using pharmacy-grade systems and temperature controls, speeding therapy delivery, and boosting resilience during disruptions. Future growth depends on regulations and transparent governance linking logistics to patient outcomes.

REFERENCES

1. Wittenauer R, Shah PD, Bacci JL, Stergachis A. Locations and characteristics of pharmacy deserts in the United States: a geospatial study. Health Aff Sch. 2024;2(4):qxae035. doi:10.1093/haschl/qxae035.

2. Ohio State University Comprehensive Cancer Center. Study finds nearly half of U.S. counties have at least one “pharmacy desert.” Published August 23, 2024. Accessed April 30, 2026. https://cancer.osu.edu/news/pharmacy-deserts-study.

3. Mathis WS, Berenbrok LA, Kahn PA, Appolon G, Tang S, Hernandez I. Vulnerability index approach to identify pharmacy deserts and keystone pharmacies. JAMA Netw Open. 2025;8(3):e250715. doi:10.1001/jamanetworkopen.2025.0715.

4. Chen Y-H, El-Adle AM, O’Brien KJ, Wentworth T, Richter HG. Drone-based medication delivery for rural, flood-prone coastal communities. PLoS One. 2025;20(10):e0333696. doi:10.1371/journal.pone.0333696.

5. Federal Aviation Administration. Package delivery by drone (Part 135). Accessed March 2, 2026. https://www.faa.gov/uas/advanced_operations/package_delivery_drone.

6. Federal Aviation Administration. Public involvement and environmental review for drone operations (NEPA & drones). Accessed March 2, 2026. https://www.faa.gov/uas/advanced_operations/nepa_and_drones.

7. Wittenauer R, Shah PD, Bacci JL, Stergachis A. Pharmacy deserts and COVID-19 risk at the census tract level in the state of Washington. Vaccine X. 2022;12:100227. Published October 17, 2022. doi:10.1016/j.jvacx.2022.100227.

8. Centers for Medicare & Medicaid Services. Retail pharmacy network access and preferred cost-sharing pharmacy network access analysis results: CY 2015 analysis; CY 2016. Published November 19, 2015. Accessed March 22, 2026. https://www.hhs.gov/guidance/sites/default/files/hhs-guidance-documents/CMS/pharmacy_access_data_availability.pdf.

9. Indian Health Service. The 2021 Indian Health Service and Tribal Health Care Facilities’ needs assessment report to Congress. Published December 2020. Accessed March 23, 2026. https://www.ihs.gov/sites/newsroom/themes/responsive2017/display_objects/documents/The-2021-IHS-Facilities-Needs-Assessment-Report-to-Congress.pdf.

10. Lavery AM, Patel A, Boehmer TK, et al. Notes from the field: pharmacy needs after a natural disaster—Puerto Rico, September-October 2017. MMWR Morb Mortal Wkly Rep. 2018;67(13):402-403. doi:10.15585/mmwr.mm6713a4.

11. Garg V, Niranjan S, Prybutok V, Pohlen T, Gligor D. Drones in last-mile delivery: a systematic review on efficiency, accessibility, and sustainability. Transp Res Part D Transp Environ. 2023;123:103831. doi:10.1016/j.trd.2023.103831.

12. Federal Aviation Administration. Draft programmatic environmental assessment for drone package delivery operations in the United States. Accessed March 2, 2026. https://www.faa.gov/uas/advanced_operations/Part_135_National_DRAFT_PEA_approved_508.pdf.

13. Texas State Board of Pharmacy. Texas pharmacy rules, 22 TAC part 15, §§291.9, 291.12. Accessed April 6, 2026. https://www.pharmacy.texas.gov/files_pdf/tsbp%20rules_master%20file.pdf.

14. Virginia Board of Pharmacy. Guidance document 110-46: delivery of dispensed drugs. Effective January 4, 2024. Accessed April 6, 2026. https://townhall.virginia.gov/L/GetFile.cfm.

15. Riverside Health. Virginia partnership launches first delivery of hypertension medications to patients via medical cargo drones. Published October 10, 2023. Accessed March 2, 2026. https://www.riversideonline.com/en/about/newscenter/innovations/virginia-partnership-launches-first-delivery-of-medical-cargo-drones.

16. University of Maryland UAS Research and Operations Center. Taking healthcare higher: drones deliver medicine in Crisfield. Published October 2025. Accessed March 2, 2026. https://eng.umd.edu/news/story/taking-healthcare-higher-drones-deliver-medicine-in-crisfield.

17. Cleveland Clinic. Delivering drugs via drone. Consult QD. Published November 2023. Accessed March 2, 2026. https://consultqd.clevelandclinic.org/delivering-drugs-via-drone.

18. United Parcel Service. UPS operates first ever U.S. drone COVID-19 vaccine delivery. Accessed March 2, 2026. https://about.ups.com/us/en/our-stories/innovation-driven/drone-covid-vaccine-deliveries.html.

19. Amazon. Get medications faster with drone delivery from Amazon Pharmacy. Updated October 13, 2023. Accessed March 2, 2026. https://www.aboutamazon.com/news/retail/amazon-pharmacy-amazon-air-prescription-drone-delivery.

20. Amazon. Amazon Pharmacy will expand same-day delivery to nearly 4,500 U.S. cities and towns by the end of 2026. Published February 2026. https://www.aboutamazon.com/news/retail/amazon-pharmacy-same-day-delivery-medication-expansion.

21. Associated Press. Amazon will start testing drones that will drop prescriptions on your doorstep, literally. Published October 18, 2023. Accessed March 2, 2026. https://apnews.com/article/e258b418f2806098de1fba17069b9fe4.

22. Fink F, Kalter J, Giesen D, et al. Identifying factors of user acceptance of a drone-based medication delivery: user-centered design approach. JMIR Hum Factors. 2024;11:e51587. doi:10.2196/51587.

23. Stolaroff JK, Samaras C, O’Neill ER, et al. Energy use and life cycle greenhouse gas emissions of drones for commercial package delivery. Nat Commun. 2018;9:409. doi:10.1038/s41467-017-02411-5.

24. Raghunatha A, Lindkvist E, Thollander P, Hansson E, Jonsson G. Critical assessment of emissions, costs, and time for last-mile goods delivery by drones versus trucks. Sci Rep. 2023;13:11814. doi:10.1038/s41598-023-38922-z.

25. Matternet. Aircraft - The M2 drone (specifications and operating envelope). Accessed March 2, 2026. https://www.matternet.com/our-system-aircraft.